Saturday, January 28, 2023

US sues opioid distributor for failing to report suspicious orders

Washington, 29 December. Authorities in the United States this Thursday condemned AmerisourceBergen, one of the country’s leading opioid distribution companies, for not reporting suspicious orders made by pharmacies and other establishments.

In a call with reporters, Luis Milione, the principal deputy administrator for the US Drug Enforcement Agency (DEA), explained that the company’s actions “have exacerbated an opioid epidemic that has resulted in hundreds of thousands of deaths over the past decade.”

During the call, Justice Department officials assured that fines for violating anti-drug regulations could reach billions of dollars.

As he explained, AmerisourceBergen continued to send orders for opioids to pharmacies that their own auditors had concluded were selling drugs to people who were possibly addicted to opioids.

In one particular case detailed by New Jersey District Attorney Philip Salling, the company learned that opioids were being sold unregulated in a parking lot at one of the pharmacies they supplied.

A company employee described the situation as “a very clear danger sign,” and yet an AmerisourceBergen subsidiary continued to send thousands of orders to the pharmacy.

Justice Department officials also pointed out that it is a civil lawsuit, not a criminal one, for which the financial sanctions are sought.

Nation World News Desk
Nation World News Desk
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news